METHOD FOR DETERMINING THE REGULATION OF XENOBIOTIC REMOVAL
Details for Australian Patent Application No. 2003256784 (hide)
Event Publications
6 November 2003 Complete Application Filed
Priority application(s): 60/398,023 24.07.02 US; 60/413,843 27.09.02 US; 60/413,866 27.09.02 US
18 March 2004 Application Open to Public Inspection
Published as AU-A-2003256784
19 May 2005 Change of Name(s) of Applicant(s), Section 104
3-Dimensional Pharmaceuticals, Inc. The name of the applicant has been changed to Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
24 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003256783-METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-Beta INHIBITORS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser